Video Results from
Published in : 2015-09-14 | by Janssen Global
Who is Janssen? We're more than 30000 people working hard to prevent, treat, cure and stop some of the most devastating and complex diseases of our time. From heart disease to HIV, Alzheimer's...
Published in : 2015-10-19 | by Johnson & Johnson
Janssen Immunology, part of our Janssen Pharmaceutical Companies of Johnson & Johnson, was featured on Discovery Channel's award-winning series Innovations with Ed Begley Jr. The segment...
Published in : 2014-06-03 | by Tableau Software
This session will share the innovative business approach in deploying a visualization and analytical culture and expertise at Janssen using Tableau. This includes the approach used to engage...
Published in : 2015-02-12 | by TheStreet
Imagine being able to identify people likely to develop a particular disease -- and then stop it before it starts. This isn't a science fiction tale. It's the ambitious goal of three research...
Published in : 2017-10-23 | by Innosight
Joaquin Duato, worldwide chair of the Janssen Pharmaceutical Companies of Johnson & Johnson, tells the story of dual transformation in practice.
Published in : 2015-07-04 | by Law Project
Published in : 2013-11-07 | by RIT BME
A fourth year biomedical engineering student, Morgan Stoessel, explains her role as an Automation Specialist at Janssen Pharmaceuticals, Inc., a division of Johnson & Johnson.
Published in : 2013-09-04 | by NJTV News
Dr. Peter Lebowitz, global head of oncology at Janssen Pharmaceuticals, says the acquisition of Aragon Pharmaceuticals could help improve treatment for cancer patients as new drugs are developed....
Published in : 2013-04-23 | by Johnson & Johnson
Transformational innovation in healthcare.
Published in : 2015-10-07 | by Janssen Global
Early intervention and advances in schizophrenia management may make a difference. (c) Janssen Pharmaceuticals, Inc. 2015. We are Janssen. We collaborate...